vs
博士伦（BLCO）与RUSH ENTERPRISES INC \TX\（RUSHA）财务数据对比。点击上方公司名可切换其他公司
RUSH ENTERPRISES INC \TX\的季度营收约是博士伦的1.2倍（$1.7B vs $1.4B），RUSH ENTERPRISES INC \TX\净利率更高（3.7% vs -4.1%，领先7.8%），博士伦同比增速更快（9.8% vs -9.0%），RUSH ENTERPRISES INC \TX\自由现金流更多（$411.6M vs $60.0M），过去两年博士伦的营收复合增速更高（13.1% vs -6.8%）
博士伦是知名眼健康产品企业，总部位于加拿大安大略省沃恩市，是全球规模最大的隐形眼镜、镜片护理产品、眼科药品、人工晶体及其他眼科手术产品供应商之一。品牌1853年由验光师约翰·鲍什与合伙人亨利·朗姆在美国纽约罗切斯特创立，曾是美国历史最悠久的持续运营企业之一，2013年被整体收购。
Rush Enterprises是总部位于美国得克萨斯州新布朗费尔斯的商用车经销商，核心业务是通过旗下Rush Truck Centers销售全新及二手卡车。2019年该公司在全美20个州运营超200家卡车中心，在加拿大设有14个网点，2020年入选财富500强榜单。
BLCO vs RUSHA — 直观对比
营收规模更大
RUSHA
是对方的1.2倍
$1.4B
营收增速更快
BLCO
高出18.8%
-9.0%
净利率更高
RUSHA
高出7.8%
-4.1%
自由现金流更多
RUSHA
多$351.6M
$60.0M
两年增速更快
BLCO
近两年复合增速
-6.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.7B |
| 净利润 | $-58.0M | $61.7M |
| 毛利率 | — | 20.4% |
| 营业利润率 | 8.0% | 4.9% |
| 净利率 | -4.1% | 3.7% |
| 营收同比 | 9.8% | -9.0% |
| 净利润同比 | -1833.3% | 1.8% |
| 每股收益（稀释后） | $-0.16 | $0.77 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLCORUSHA
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.4B | $1.7B | ||
| Q3 25 | $1.3B | $1.8B | ||
| Q2 25 | $1.3B | $1.8B | ||
| Q1 25 | $1.1B | $1.8B | ||
| Q4 24 | $1.3B | $1.9B | ||
| Q3 24 | $1.2B | $1.8B | ||
| Q2 24 | $1.2B | $1.9B |
净利润BLCORUSHA
| Q1 26 | — | $61.7M | ||
| Q4 25 | $-58.0M | $64.3M | ||
| Q3 25 | $-28.0M | $66.7M | ||
| Q2 25 | $-62.0M | $72.4M | ||
| Q1 25 | $-212.0M | $60.3M | ||
| Q4 24 | $-3.0M | $74.8M | ||
| Q3 24 | $4.0M | $79.1M | ||
| Q2 24 | $-151.0M | $78.7M |
毛利率BLCORUSHA
| Q1 26 | — | 20.4% | ||
| Q4 25 | — | 20.8% | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | — | 20.7% | ||
| Q1 25 | — | 20.3% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 21.0% | ||
| Q2 24 | — | 20.2% |
营业利润率BLCORUSHA
| Q1 26 | — | 4.9% | ||
| Q4 25 | 8.0% | 5.5% | ||
| Q3 25 | 7.4% | 5.6% | ||
| Q2 25 | -0.9% | 6.0% | ||
| Q1 25 | -7.3% | 5.2% | ||
| Q4 24 | 6.8% | 5.8% | ||
| Q3 24 | 3.6% | 6.7% | ||
| Q2 24 | 2.1% | 6.4% |
净利率BLCORUSHA
| Q1 26 | — | 3.7% | ||
| Q4 25 | -4.1% | 3.8% | ||
| Q3 25 | -2.2% | 3.7% | ||
| Q2 25 | -4.9% | 3.9% | ||
| Q1 25 | -18.6% | 3.4% | ||
| Q4 24 | -0.2% | 3.9% | ||
| Q3 24 | 0.3% | 4.4% | ||
| Q2 24 | -12.4% | 4.1% |
每股收益（稀释后）BLCORUSHA
| Q1 26 | — | $0.77 | ||
| Q4 25 | $-0.16 | $0.81 | ||
| Q3 25 | $-0.08 | $0.83 | ||
| Q2 25 | $-0.18 | $0.90 | ||
| Q1 25 | $-0.60 | $0.73 | ||
| Q4 24 | $-0.00 | $-95.13 | ||
| Q3 24 | $0.01 | $0.97 | ||
| Q2 24 | $-0.43 | $97.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $383.0M | — |
| 总债务越低越好 | $5.0B | $277.8M |
| 股东权益账面价值 | $6.4B | $2.3B |
| 总资产 | $14.0B | $4.5B |
| 负债/权益比越低杠杆越低 | 0.78× | 0.12× |
8季度趋势，按日历期对齐
现金及短期投资BLCORUSHA
| Q1 26 | — | — | ||
| Q4 25 | $383.0M | $212.6M | ||
| Q3 25 | $310.0M | $242.0M | ||
| Q2 25 | $266.0M | $211.1M | ||
| Q1 25 | $202.0M | $228.7M | ||
| Q4 24 | $305.0M | $228.1M | ||
| Q3 24 | $329.0M | $185.1M | ||
| Q2 24 | $285.0M | $167.3M |
总债务BLCORUSHA
| Q1 26 | — | $277.8M | ||
| Q4 25 | $5.0B | $274.8M | ||
| Q3 25 | $5.0B | — | ||
| Q2 25 | $5.0B | — | ||
| Q1 25 | $4.8B | — | ||
| Q4 24 | $4.8B | $408.4M | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — |
股东权益BLCORUSHA
| Q1 26 | — | $2.3B | ||
| Q4 25 | $6.4B | $2.2B | ||
| Q3 25 | $6.4B | $2.2B | ||
| Q2 25 | $6.4B | $2.2B | ||
| Q1 25 | $6.4B | $2.2B | ||
| Q4 24 | $6.5B | $2.1B | ||
| Q3 24 | $6.6B | $2.1B | ||
| Q2 24 | $6.5B | $2.0B |
总资产BLCORUSHA
| Q1 26 | — | $4.5B | ||
| Q4 25 | $14.0B | $4.4B | ||
| Q3 25 | $13.8B | $4.6B | ||
| Q2 25 | $13.8B | $4.7B | ||
| Q1 25 | $13.4B | $4.7B | ||
| Q4 24 | $13.5B | $4.6B | ||
| Q3 24 | $13.5B | $4.6B | ||
| Q2 24 | $13.3B | $4.5B |
负债/权益比BLCORUSHA
| Q1 26 | — | 0.12× | ||
| Q4 25 | 0.78× | 0.12× | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | 0.77× | — | ||
| Q1 25 | 0.76× | — | ||
| Q4 24 | 0.74× | 0.19× | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 0.71× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $136.0M | — |
| 自由现金流经营现金流 - 资本支出 | $60.0M | $411.6M |
| 自由现金流率自由现金流/营收 | 4.3% | 24.4% |
| 资本支出强度资本支出/营收 | 5.4% | 2.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-66.0M | $828.4M |
8季度趋势，按日历期对齐
经营现金流BLCORUSHA
| Q1 26 | — | — | ||
| Q4 25 | $136.0M | $112.9M | ||
| Q3 25 | $137.0M | $367.8M | ||
| Q2 25 | $35.0M | $227.6M | ||
| Q1 25 | $-25.0M | $153.5M | ||
| Q4 24 | $22.0M | $392.3M | ||
| Q3 24 | $154.0M | $111.7M | ||
| Q2 24 | $15.0M | $270.6M |
自由现金流BLCORUSHA
| Q1 26 | — | $411.6M | ||
| Q4 25 | $60.0M | $31.9M | ||
| Q3 25 | $63.0M | $271.2M | ||
| Q2 25 | $-54.0M | $113.8M | ||
| Q1 25 | $-135.0M | $45.1M | ||
| Q4 24 | $-70.0M | $263.5M | ||
| Q3 24 | $94.0M | $-20.0M | ||
| Q2 24 | $-57.0M | $177.2M |
自由现金流率BLCORUSHA
| Q1 26 | — | 24.4% | ||
| Q4 25 | 4.3% | 1.9% | ||
| Q3 25 | 4.9% | 15.2% | ||
| Q2 25 | -4.2% | 6.2% | ||
| Q1 25 | -11.9% | 2.6% | ||
| Q4 24 | -5.5% | 13.7% | ||
| Q3 24 | 7.9% | -1.1% | ||
| Q2 24 | -4.7% | 9.1% |
资本支出强度BLCORUSHA
| Q1 26 | — | 2.0% | ||
| Q4 25 | 5.4% | 4.8% | ||
| Q3 25 | 5.8% | 5.4% | ||
| Q2 25 | 7.0% | 6.2% | ||
| Q1 25 | 9.7% | 6.2% | ||
| Q4 24 | 7.2% | 6.7% | ||
| Q3 24 | 5.0% | 7.3% | ||
| Q2 24 | 5.9% | 4.8% |
现金转化率BLCORUSHA
| Q1 26 | — | — | ||
| Q4 25 | — | 1.75× | ||
| Q3 25 | — | 5.51× | ||
| Q2 25 | — | 3.14× | ||
| Q1 25 | — | 2.55× | ||
| Q4 24 | — | 5.25× | ||
| Q3 24 | 38.50× | 1.41× | ||
| Q2 24 | — | 3.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLCO
| Overthe Counter Products | $489.0M | 35% |
| Pharmaceuticals | $378.0M | 27% |
| Other | $263.0M | 19% |
| Surgical | $249.0M | 18% |
| Brandedand Other Generic Products | $14.0M | 1% |
| Other Revenues | $3.0M | 0% |
| Pharmaceutical Products | $2.0M | 0% |
RUSHA
| New and used commercial vehicle sales | $955.1M | 57% |
| Aftermarket products and services sales | $627.2M | 37% |
| Lease and rental sales | $92.3M | 5% |
| Finance and insurance | $5.6M | 0% |
